WAI CHUN BIOTEC (00660) released its interim performance results, with a net loss attributable to shareholders of HK$13.66 million, a year-on-year increase of 102.87%.

WAI CHUN BIOTEC (00660) announced its interim results for the 6-month period ending December 31, 2024. The company reported a revenue of HK$161 million, a decrease of 15.38% compared to the previous year. Shareholders' loss attributable to equity holders widened to HK$13.661 million, an increase of 102.87% year-on-year. Earnings per share was HK$0.0797.